TriMark Publications, July 2011, Pages: 201
for PersonalizedMedicine
2.8 Companion Diagnostics Play an Increasing Role in Cancer Care
2.9 Specific Examples of Clinical Situations where Companion Diagnostics are being Deployed
2.9.1 Epidermal Growth Factor
GlobalData, Sep 2011, Pages: 7
PersonalizedMedicine for Cancer
Summary
GlobalData, the industry analysis specialist, has released its new view point, “PersonalizedMedicine for Cancer”. The report is an essential source
Select Biosciences Ltd, July 2009, Pages: 196
This is the latest and most up-to-date market analysis report addressing microRNA diagnostics, therapeutics and cancerpersonalizedmedicine. The cancerpersonalizedmedicine marketplace provides
John Wiley and Sons Ltd, Dec 2010, Pages: 252
of individualized oncology to help improve the global concept of the personalizedcancer care, and identify commonalities, pitfalls, and steps forward Towards PersonalizedMedicine for Cancer
Decision Resources, Inc., Oct 2006, Pages: 30
Center Institute
- YM BioSciences’ TheraCIM hR3 (nimotuzumab) Companion Diagnostics: Enabling PersonalizedMedicines in Cancer
Pan Stanford Publishing Pte. Ltd., April 2010, Pages: 351
This unique book provides a thorough overview of developing molecular cancer diagnostic assays, which are the prerequisites for optimal solutions within personalizedcancermedicine. The book takes
Datamonitor, Oct 2011, Pages: 100
methodology Market and Product Forecasts: Targeted Cancer Therapies - Trend towards personalizedmedicine will lead to market fragmentation
Datamonitor, Oct 2009, Pages: 51
Health
- Keryx Biopharmaceuticals, Inc.
- Merck KGaA
- Schering-Plough Corporation Pipeline Insight: Colorectal Cancer - Growing Trend Towards PersonalizedMedicine
Jain PharmaBiotech, Feb 2012, Pages: 780
Personalizedcancer vaccines
Antisense therapy
RNA interference
MicroRNAs
8. PersonalizedMedicine in Major Therapeutic Areas
Introduction
Management of infections
Management of HIV
CD4 counts as a guide
GBI Research, Dec 2010, Pages: 124
in Cancer Research, Global, Cancer Biomarkers Market Revenues ($bn), 2007–2016
Table 29: PersonalizedMedicine Market, Global, Biomarkers in Cancer Research, Breast Cancer Biomarkers Market Revenues ($m
Jain PharmaBiotech, Feb 2012, Pages: 639
TOR signaling defects
Combining novel anticancer approaches
Personalized therapy of cancer
Challenges of cancer classification
Design of future cancer therapies
Personalized drug development in oncology
Role
Jain PharmaBiotech, Feb 2012, Pages: 225
and cancer to diagnosis of several other diseases. Other important applications are drug discovery, and development of personalizedmedicine.
The chapter on markets provides a global perspective
Future Medicine Ltd, Aug 2010, Pages: 92
of biomarkers that can detect cancer early or monitor disease progression enable us to personalizemedicine and improve the care of cancer patients. This Sepcial Focus Issue of the peer-reviewed journal
Select Biosciences Ltd, Jan 2011, Pages: 139
and expanding driven by the greater emphasis on personalizedmedicine especially in the cancer/oncology space.
Cancer vaccines can be generated using a number of different approaches and this report describes
Jain PharmaBiotech, Feb 2012, Pages: 864
with diagnostics and will thus play an important role in the development of personalizedmedicine. Biomarkers play a role in use of pharmacogenetics, pharmacogenomics and pharmacoproteomics for development
Business Insights, Aug 2009, Pages: 141
Overview
Breast cancer
Colorectal cancer
Lung cancer
Other diseases
Future outlook
Chapter 1 Overview
Summary
Introduction
The rise of personalizedmedicine
Population and disease-based biobanks
Select Biosciences Ltd, Oct 2011, Pages: 139
with Physiological Situations and Various Disease Processes
- Cancer
- Hematological Cancers, Solid Tumors
- CancerPersonalizedMedicine
- Breast Cancer
- Lung Cancer
- Prostate Cancer
- Pancreatic Cancer
- Normal
TriMark Publications, May 2011, Pages: 1784
- Cancer Cell Therapy Markets
- Cancer Diagnostic Testing World Markets
- Cancer Therapeutics Markets
- Cancer Vaccines Markets
- Companion Diagnostics in PersonalizedMedicine and Cancer Therapy
- Cytology
Elsevier Science and Technology, Oct 2011, Pages: 330
in Cancer Chemoresistance
10. DNA Repair Signaling Targets
11. Redox Regulation of DNA Repair and Therapeutic
12. PersonalizedCancerMedicine: DNA Repair Alterations is a Promising Predictive Marker
